St Remy meeting focuses on lipid-based drug delivery
Researchers gathered in the south of France to discuss how the pharmaceutical industry can embrace lipid-based drug delivery as a viable alternative to traditional formulation approaches.
Archives for September 5, 2006
Chemokine Therapeutics issued chemokine analog patent
Chemokine Therapeutics has announced it has received a patent relating to chemokine analogs for the treatment of human disease, which includes autoimmune diseases, cancer, cardiovascular disease, and inflammatory disorders such as rheumatoid arthritis.
Dalton Pharma Services introduces new medicinal chemistry services
Dalton Pharma Services has introduced a range of new medicinal chemistry services that are available to companies involved in drug discovery that wish to utilise additional scientific and managerial expertise as well as specialised equipment.
Novel screening method speeds up cancer drug search
Researchers have developed a new technique that they claim will vastly speed up the search for new cancer drugs and antibiotics that has proved problematic and time expensive in the drug's development cycle.
AtCor secures $1.5m cardiovascular trial contract
Australia's AtCor Medical will supply an undisclosed US pharmaceutical company with central blood pressure reading and clinical trial support services in a deal worth $1.48m (€1.2m).
Novartis drinks to Exjade after EU approval
Swiss drugmaker Novartis is celebrating the approval of Exjade in the EU for the treatment of patients with transfusional iron overload, hoping for a blockbuster as the drug offers an oral single daily-dose alternative to cumbersome infusions via pump.
Clinical trials industry struggling with drug accountability
The clinical trials industry is struggling to cope with the burden of maintaining adequate drug accountability documentation for regulatory compliance.